acarix

Corporate Information, English, IR, MAR, News, Other Corporate Information, Regulatory

November 18, 2024

02 Oct 2023

Acarix appoints industry veteran Fred Colen as acting CEO during temporary medical leave of CEO Helen Ljungdahl Round

Acarix, a leader in acoustic and AI-based cardiac diagnostics, announces that CEO Helen Ljungdahl Round will be taking a temporary medi...

Continue reading

acarix

Corporate Information, IR, MAR, News, Other Corporate Information, Regulatory, Swedish

November 18, 2024

02 Oct 2023

Acarix utser industriledaren Fred Colen som tillförordnad VD medan VD Helen Ljungdahl Round tillfälligt sjukskrivs

Acarix, ledande inom akustisk och AI-baserad hjärtdiagnostik, meddelar idag att VD Helen Ljungdahl Round sjukskrivits för beh...

Continue reading

acarix

Corporate Action, English, IR, Issuance, MAR, News, Regulatory, Shares

November 18, 2024

11 Sep 2023

Acarix resolves on a rights issue of approximately SEK 54 million fully guaranteed by, among others, a Danish life science fund

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, WHETHER DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, ...

Continue reading

acarix

Corporate Action, IR, Issuance, MAR, News, Regulatory, Shares, Swedish

November 18, 2024

11 Sep 2023

Acarix beslutar om företrädesemission om cirka 54 MSEK fullt garanterad av bland annat en dansk life science fond

EJ FÖR OFFENTLIGGÖRANDE, DISTRIBUTION ELLER PUBLICERING, VARE SIG DIREKT ELLER INDIREKT, INOM ELLER TILL USA, AUSTRALIEN, HON...

Continue reading

acarix

Corporate Action, English, IR, Issuance, MAR, News, Regulatory, Shares

November 18, 2024

04 Apr 2023

Acarix carries out a directed share issue amounting to approximately SEK 9.5 million

THIS PRESS RELEASE IS NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, ...

Continue reading

acarix

Corporate Action, IR, Issuance, MAR, News, Regulatory, Shares, Swedish

November 18, 2024

04 Apr 2023

Acarix genomför en riktad nyemission om cirka 9,5 MSEK

DETTA PRESSMEDDELANDE ÄR EJ FÖR OFFENTLIGGÖRANDE, DISTRIBUTION ELLER PUBLICERING, VARKEN DIREKT ELLER INDIREKT, INOM ELL...

Continue reading

acarix

Corporate Information, English, IR, MAR, News, Other Corporate Information, Regulatory

November 18, 2024

21 Feb 2023

Acarix receives breakthrough order from US Veterans Health Administration

Acarix, a leader in acoustic and AI-based cardiac diagnostics, announces today the first order from the US Veterans Health Administrati...

Continue reading

acarix

Corporate Information, IR, MAR, News, Other Corporate Information, Regulatory, Swedish

November 18, 2024

21 Feb 2023

Acarix erhåller genombrottsorder från US Veterans Health Administration

Acarix, ledande inom akustisk och AI-baserad hjärtdiagnostik, bekräftar idag att bolaget erhållit den första order...

Continue reading

acarix

Corporate Information, English, IR, MAR, News, Other Corporate Information, Regulatory

November 18, 2024

22 Nov 2022

Acarix resolves on a partially guaranteed rights issue of approximately SEK 52.9 million

THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, A...

Continue reading

acarix

Corporate Information, IR, MAR, News, Other Corporate Information, Regulatory, Swedish

November 18, 2024

22 Nov 2022

Acarix beslutar om partiellt garanterad företrädesemission om cirka 52,9 MSEK

DETTA PRESSMEDDELANDE ÄR EJ FÖR OFFENTLIGGÖRANDE, DISTRIBUTION ELLER PUBLICERING, VARKEN DIREKT ELLER INDIREKT, INOM ELL...

Continue reading

acarix

English, Interim, IR, MAR, News, Q3, Regulatory, Report

November 18, 2024

16 Nov 2022

Full focus on the US market with strong interest from healthcare providers, reimbursement code in place and collaboration with ACC

Acarix is now taking an important strategic step, putting full commercial focus on the US market. We have the key building blocks in pl...

Continue reading

acarix

Interim, IR, MAR, News, Q3, Regulatory, Report, Swedish

November 18, 2024

16 Nov 2022

Fullt fokus på USA med stort intresse från sjukvården, egen reimbursementkod på plats och samarbete med ACC

Acarix tar nu ett viktigt strategiskt kliv och lägger fullt kommersiellt fokus på USA-marknaden. Vi har de viktiga byggstena...

Continue reading